Images List Premium Download Classic

Immune Response

Immune Response-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Strings of epitopes useful in diagnosing and eliciting immune responses to sexually transmitted infections
Washington State University
July 12, 2018 - N°20180196047

The invention provides methods and compositions for detecting and diagnosing sexually transmitted infections using a string of epitopes (soe) specific for detection of causative microorganisms. The antigenic epitopes may be single epitope sequences, a plurality of epitope sequences joined by repeats of glycine (-gg-) and/or lysine (-kk-) to form a series of epitopes (soe), or nucleotide sequences encoding one ...
Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation ...
Centre National De La Recherche Scientifique
July 12, 2018 - N°20180195088

The invention relates to a recombinant measles virus expressing a heterologous amino acid sequence derived from an antigen of a determined rna virus, said recombinant measles virus being capable of eliciting a humoral and/or cellular immune response against measles virus or against said rna virus or against both measles virus and against said rna virus. It also relates to ...
Broad spectrum conjugate vaccine to prevent klebsiella pneumoniae and pseudomonas aeruginosa infections
July 12, 2018 - N°20180194812

The present invention is drawn to conjugates and vaccine compositions comprising a pseudomonas flagellin or an antigenic fragment or derivative thereof linked to one or more klebsiella surface polysaccharide antigens, such as klebsiella pneumoniae o polysaccharide from serovars o1, o2a, o2a,c, o3, o4, o5, o7, o8 and o12. The present invention also provides serovar reagent strains to ...
Immune Response Patent Pack
Download 464+ patent application PDFs
Immune Response Patent Applications
Download 464+ Immune Response-related PDFs
For professional research & prior art discovery
inventor
  • 464+ full patent PDF documents of Immune Response-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
Selecta Biosciences, Inc.
July 12, 2018 - N°20180193482

Provided herein are methods and related compositions for administering viral vectors and synthetic nanocarriers comprising an immunosuppressant. In some embodiments, the methods and compositions provided herein achieve improved transgene expression and/or immune response reduction, such as downregulated igm and/or igg immune responses..
Novel mucosal vaccination approach for herpes simplex virus type-2
Biomedical Research Models, Inc.
July 12, 2018 - N°20180193448

Methods and kits for immunizing animals (e.g. Mammals) against viral antigens, including herpes-simplex virus type 2 are provided.
Concomitant dengue and yellow fever vaccination
Sanofi Pasteur
July 12, 2018 - N°20180193447

The present invention relates to a yellow fever (yf) vaccine for use in a method for inducing a protective immune response against yellow fever, wherein said method comprises concomitantly administering said yellow fever vaccine to a human subject together with a tetravalent dengue vaccine which comprises a live attenuated dengue virus of each of serotypes 1 to 4. This invention also pertains ...
Immune Response Patent Pack
Download 464+ patent application PDFs
Immune Response Patent Applications
Download 464+ Immune Response-related PDFs
For professional research & prior art discovery
inventor
  • 464+ full patent PDF documents of Immune Response-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Induction of lamina propria regulatory t cells
President And Fellows Of Harvard College
July 12, 2018 - N°20180193391

Described herein are methods and compositions for the induction of the production of regulatory t cells and for the treatment and/or prevention of diseases associated with pathological immune responses, such as inflammatory bowel diseases.. .
Methods and compositions for combination immunotherapy
Etubics Corporation
July 05, 2018 - N°20180187211

Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.. .
Compositions comprising nucleic acids and methods of using the same
Massachusetts Institute Of Technology
July 05, 2018 - N°20180187186

The disclosure relates to compositions comprising and methods for chemical modification of single guide rna (sgrna), tracrrna and/or crrna used individually or in combination with one another or cas system components. Compositions comprising modified ribonucleic acids have been designed with chemical modification for even higher efficiency as unmodified native strand of sgrna.
Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
Northwest Biotherapeutics, Inc.
July 05, 2018 - N°20180187145

The present disclosure provides populations of cells comprising partially mature and optimally activated dendritic cells that can be used for administration to individuals having a cancer and/or tumor. Partially matured dendritic cells, those contacted with a dendritic cell maturation agent for about 10 to about 19 hours, upon administration efficiently take up and process tumor antigens in the area of the ...
Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
July 05, 2018 - N°20180186792

Wherein a is ch or n, p is in a range from 1 to 50, r″ is a bond or -alkylene-o—, r′ is alkylene that is optionally interrupted or terminated with one or more amide or ether groups, and e is an amine- or thiol-reactive group. Pharmaceutical compositions containing the compound or the conjugate, methods of making a conjugate, ...
Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
Trieza Therapeutics, Inc.
July 05, 2018 - N°20180185515

Disclosed herein are compositions and methods for treating cancer in a subject. This involves administering an oncolytic virus containing a heterologous dna sequence encoding one or more immunomodulatory and/or immunostimulatory polypeptide(s) of interest to the subject under conditions effective to enhance an anti-tumor immune response in the subject, and to treat cancer.
Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
City Of Hope
July 05, 2018 - N°20180185497

The present disclosure relates to an isolated compound including a phosphorothioated oligodeoxynucleotide (odn) sequence conjugated to a short-activating rna (sarna) or an antisense oligonucleotide sequence (aso), compositions of such a compound, and method of treatment of cancer and autoimmune diseases (with or without stimulating immune response), method of immune stimulation, method of activating cebpa, and method of reducing activity of ...
Immune Response Patent Pack
Download 464+ patent application PDFs
Immune Response Patent Applications
Download 464+ Immune Response-related PDFs
For professional research & prior art discovery
inventor
  • 464+ full patent PDF documents of Immune Response-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine
Bavarian Nordic A/s
July 05, 2018 - N°20180185466

The present invention relates to modified poxviral vectors and to methods of making and using the same. In particular, the invention relates to recombinant modified vaccinia virus ankara-based (mva-based) vaccine against fmdv infection and to related products, methods and uses.
Chimeric proteins
The Australian National University
July 05, 2018 - N°20180185464

The present invention is directed generally to chimeric proteins that can facilitate targeting of nanoparticulate carriers to antigen presenting cells, and to nanoparticulate carriers comprising these chimeric proteins. The invention is also directed to methods of internalising an antigen in an antigen presenting cell, and methods of eliciting an immune response to an antigen in a subject, using the nanoparticulate ...
Allogenic tumor cell vaccine
Alloplex Biotherapeutics
July 05, 2018 - N°20180185463

The described invention provides a tumor cell vaccine comprising genetically modified tumor cell line of a particular tumor type that stably expresses high levels of two or more immunomodulators. According to some embodiments, an immunogenic amount of the tumor cell line variants may be selected for concomitant expression of two or more of recombinant membrane expressed igg1, cd40l, tnf-alpha, ...
Immune checkpoint chimeric antigen receptors therapy
The Johns Hopkins University
July 05, 2018 - N°20180185434

In some aspects, the embodiments relate to compositions and methods related to chimeric transmembrane proteins. The chimeric transmembrane proteins may comprise the extracellular domain of an inhibitory receptor, and an intracellular signaling domain that can activate an immune response..
Milk-derived microvesicle compositions and related methods
University Of Louisville Research Foundation, Inc.
July 05, 2018 - N°20180185285

A composition is provided that comprises a therapeutic agent encapsulated by a milk-derived microvesicle. The compositions can include therapeutic agents such as phytochemical agents or chemotherapeutic agents, while the milk-derived microvesicle can be derived from raw milk or colostrum.
Allogeneic autophagosome-enriched composition for the treatment of disease
Providence Health & Sevices-oregon
June 28, 2018 - N°20180179598

A method is presented for screening cells that produce allogeneic autophagosome enriched compositions able to induce expression of a selective marker on a subpopulation of peripheral blood mononuclear cells, the method comprising contacting a cell with a proteasome inhibitor, contacting the cell with a lysosome inhibitor, harvesting the resulting autophagosomes, determining a molecular signature of the harvested autophagosomes, and selecting ...
Methods and compositions for treating celiac disease
Beth Israel Deaconess Medical Center, Inc.
June 28, 2018 - N°20180179268

The invention features the treatment of gastrointestinal disorders associated with an innate immune response triggered by alpha amylase inhibitor cm3, alpha amylase inhibitor 0.19 (0.19), cm1, cm2, cma, cmd, cm 16, cmb, cmx1/cmx3, cmx2, and/or alpha amylase inhibitor 0.53 (0.53). To this end, the invention features pharmaceutical compositions including neutralizing antibodies to cm3, 0.19, cm1, cm2, cma, cmd, cm16, cmb, cmx1/cmx3, cmx2, and/...
Ceacam1 mediated protective immunity
June 28, 2018 - N°20180177902

The presently described technology relates to the modulation of specific immune responses to create a protective immunity in the treatment of autoimmune diseases and diseases requiring the transplantation of tissue. In particular, the present technology relates to the suppression of immune responses in a targeted fashion, by increasing the functional concentration of the ceacam1 protein in a target tissue to ...
Loading